1. Home
  2. OXM vs CSTL Comparison

OXM vs CSTL Comparison

Compare OXM & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oxford Industries Inc.

OXM

Oxford Industries Inc.

HOLD

Current Price

$45.32

Market Cap

675.3M

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$21.60

Market Cap

597.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OXM
CSTL
Founded
1942
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
675.3M
597.8M
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
OXM
CSTL
Price
$45.32
$21.60
Analyst Decision
Hold
Strong Buy
Analyst Count
4
6
Target Price
$38.00
$45.50
AVG Volume (30 Days)
245.2K
491.9K
Earning Date
06-10-2026
05-06-2026
Dividend Yield
6.80%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,477,834,000.00
$344,229,000.00
Revenue This Year
$2.85
$2.42
Revenue Next Year
$2.63
$12.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.66
52 Week Low
$30.57
$14.59
52 Week High
$56.34
$44.28

Technical Indicators

Market Signals
Indicator
OXM
CSTL
Relative Strength Index (RSI) 54.61 51.58
Support Level $35.94 $17.72
Resistance Level $48.02 $22.18
Average True Range (ATR) 2.23 1.11
MACD 0.36 0.31
Stochastic Oscillator 61.85 85.95

Price Performance

Historical Comparison
OXM
CSTL

About OXM Oxford Industries Inc.

Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company's business is organized as: Tommy Bahama, Lilly Pulitzer, Johnny Was and Emerging Brands reportable segments. Geographically, the company operates in United States as well as Internationally.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: